Latest Breaking News On - Data show noninferiority - Page 1 : comparemela.com

Phase 3 data for efsitora alfa showed noninferiority to once-daily basal insulins in two studies of people with type 2 diabetes.

Los angelesEli lillyAnnel petersEuropean association for the study of diabetesDrug administration endocrinologicNovo nordiskUniversity of southern california westside centerMetabolic drugs advisory committeeDrug administrationMetabolic drugs advisoryAffordability areSouthern california westside centerMedscape medical newsData show noninferiorityDaily basalEuropean association